- Home
- RFI vs MGTX Comparison
RFI vs MGTX Comparison
Compare RFI & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFI
- MGTX
- Stock Information
- Founded
- RFI 1992
- MGTX 2015
- Country
- RFI United States
- MGTX United States
- Employees
- RFI N/A
- MGTX N/A
- Industry
- RFI Investment Managers
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RFI Finance
- MGTX Health Care
- Exchange
- RFI Nasdaq
- MGTX Nasdaq
- Market Cap
- RFI 344.7M
- MGTX 411.4M
- IPO Year
- RFI N/A
- MGTX N/A
- Fundamental
- Price
- RFI $12.73
- MGTX $5.98
- Analyst Decision
- RFI
- MGTX Strong Buy
- Analyst Count
- RFI 0
- MGTX 2
- Target Price
- RFI N/A
- MGTX $22.50
- AVG Volume (30 Days)
- RFI 69.8K
- MGTX 325.1K
- Earning Date
- RFI 01-01-0001
- MGTX 11-12-2024
- Dividend Yield
- RFI 8.25%
- MGTX N/A
- EPS Growth
- RFI N/A
- MGTX N/A
- EPS
- RFI N/A
- MGTX N/A
- Revenue
- RFI N/A
- MGTX $8,122,000.00
- Revenue This Year
- RFI N/A
- MGTX $133.83
- Revenue Next Year
- RFI N/A
- MGTX $655.34
- P/E Ratio
- RFI N/A
- MGTX N/A
- Revenue Growth
- RFI N/A
- MGTX 26.87
- 52 Week Low
- RFI $9.62
- MGTX $3.49
- 52 Week High
- RFI $12.52
- MGTX $7.60
- Technical
- Relative Strength Index (RSI)
- RFI 44.70
- MGTX 78.17
- Support Level
- RFI $12.88
- MGTX $3.97
- Resistance Level
- RFI $13.14
- MGTX $6.24
- Average True Range (ATR)
- RFI 0.17
- MGTX 0.33
- MACD
- RFI -0.02
- MGTX 0.20
- Stochastic Oscillator
- RFI 21.74
- MGTX 88.56
About RFI Cohen & Steers Total Return Realty Fund Inc.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.